awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38262816-267C40D0-F0AD-40F6-865D-46D25732FADA
Q38262816-267C40D0-F0AD-40F6-865D-46D25732FADA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38262816-267C40D0-F0AD-40F6-865D-46D25732FADA
Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development.
P2860
Q38262816-267C40D0-F0AD-40F6-865D-46D25732FADA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38262816-267C40D0-F0AD-40F6-865D-46D25732FADA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a18cd7c86e450047aa02a98fbecb8f17cf2b3f94
P2860
SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity.